Pao-Yeh Wang
Papers
1
Total Citations
6
H-Index
1
About
Pao-Yeh Wang is a medicinal chemist and molecular imaging researcher whose work focuses on the development of novel positron emission tomography (PET) radiotracers for imaging neuroinflammation. His key research areas include the synthesis of fluorine-18 labeled compounds, inducible nitric oxide synthase (iNOS) targeting, and the integration of PET with magnetic resonance imaging (MRI) for enhanced neurological diagnostics. Wang’s most notable contribution is the automated synthesis and evaluation of a spiroquinazoline-based radiotracer designed to image iNOS, a critical biomarker of microglial activation in neuroinflammatory diseases. This work, published in 2021, has garnered 6 citations and represents a strategic advance in the molecular imaging of brain inflammation. By developing a radiotracer suitable for simultaneous PET/MR imaging, Wang has opened new avenues for non-invasive, real-time visualization of neuroinflammatory processes, which could significantly impact the study and diagnosis of conditions such as Alzheimer’s disease, multiple sclerosis, and traumatic brain injury. His research exemplifies the intersection of organic synthesis, radiochemistry, and translational neuroscience, offering a promising tool for both preclinical research and future clinical applications.
Research Focus
Key Achievements
Top Papers
- 1